Back to results
US 2026/0306467 A1Published application
Amlodipine formulations
AssigneeAzurity Pharmaceuticals, Inc.
InventorsScott BRAUER, Gerold L. MOSHER
Life of this patent
Estimating the term…
Abstract
Provided herein are stable amlodipine oral liquid formulations. Also provided herein are methods of using amlodipine oral liquid formulations for the treatment of certain diseases including hypertension and Coronary Artery Disease (CAD).
Claims12
An oral liquid formulation, comprising:
- (i) a pharmaceutically acceptable salt of amlodipine;
- (ii) a buffer;
- (iii) water;
- and
- (iv) optionally one or more agents selected from the group consisting of preservatives, flavoring agents, sweetening agents, surfactants, suspensions aids, and antifoaming agents;
- wherein the formulation is stable at about 5±5° C. to about 25±5° C. for at least 12 months.
3 more elements
Dependencies are inferred from the claim text.